Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort Study
European Journal of Clinical Microbiology & Infectious Diseases Jan 12, 2018
Leone S, et al. - Incidence rates of and predictors for any antiretroviral (ART) drug discontinuation by HCV infection status were determined in a large Italian cohort of HIV infected patients. A marginal risk increase of darunavir/r discontinuation was evident among HIV/HCV coinfected patients compared with those without coinfection. This elevated risk might be due to any reason.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
